全文获取类型
收费全文 | 74669篇 |
免费 | 3935篇 |
国内免费 | 288篇 |
学科分类
医药卫生 | 78892篇 |
出版年
2023年 | 723篇 |
2022年 | 1630篇 |
2021年 | 2726篇 |
2020年 | 1515篇 |
2019年 | 1976篇 |
2018年 | 2282篇 |
2017年 | 1803篇 |
2016年 | 1982篇 |
2015年 | 2152篇 |
2014年 | 2862篇 |
2013年 | 3622篇 |
2012年 | 5226篇 |
2011年 | 5350篇 |
2010年 | 2813篇 |
2009年 | 2273篇 |
2008年 | 3915篇 |
2007年 | 4075篇 |
2006年 | 3847篇 |
2005年 | 3534篇 |
2004年 | 3386篇 |
2003年 | 3096篇 |
2002年 | 2781篇 |
2001年 | 925篇 |
2000年 | 864篇 |
1999年 | 813篇 |
1998年 | 493篇 |
1997年 | 321篇 |
1992年 | 471篇 |
1991年 | 399篇 |
1990年 | 413篇 |
1989年 | 476篇 |
1988年 | 528篇 |
1987年 | 508篇 |
1986年 | 507篇 |
1985年 | 480篇 |
1984年 | 426篇 |
1983年 | 321篇 |
1979年 | 550篇 |
1978年 | 347篇 |
1977年 | 288篇 |
1975年 | 355篇 |
1974年 | 522篇 |
1973年 | 526篇 |
1972年 | 437篇 |
1971年 | 408篇 |
1970年 | 395篇 |
1969年 | 416篇 |
1968年 | 361篇 |
1967年 | 280篇 |
1966年 | 296篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
A case of Rubinstein‐Taybi syndrome associated with growth hormone deficiency in childhood 下载免费PDF全文
2.
3.
4.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献5.
Flavia Temperilli Aldona Rina Isabella Massimi Anna Lisa Montemari Maria Luisa Guarino Alessandra Zicari 《Platelets》2015,26(8):783-787
Serum thromboxane-B2 (TxB2), together with arachidonic acid (AA)-induced platelet aggregation, are, at the moment, the most used tests to identify patients displaying high on-aspirin treatment platelet reactivity (HAPR). Both tests are specific for aspirin action on cyclooxygenase-1. While the correlation between serum TxB2 assay and clinical outcome is established, data are conflicting with regard to aspirin treatment and a possible association with AA-stimulated platelet markers and clinical outcome. To understand such discrepancy, we performed a retrospective study to compare both assays. We collected data from 132 patients receiving a daily dose of aspirin (100?mg/day) and data from 48 patients receiving aspirin on alternate days. All Patients who received a daily dose of aspirin were studied for AA-induced platelet aggregation together with serum TxB2 levels and AA-induced TxB2 formation was also studied in 71 patients out of entire population. Consistent with recommendations in the literature, we defined HAPR by setting a cut-off point at 3.1?ng/ml for serum levels of thromboxane B2 and 20% for AA-induced platelet aggregation. According to this cut-off point, we divided our overall population into two groups: (1) TxB2?<?3.1?ng/ml and (2) TxB2?>?3.1?ng/ml. We found low agreement between such tests to identify patients displaying HAPR. Our results show that AA-induced platelet aggregation >20% identify a smaller number of HAPR patients in comparison with TxB2. A good correlation between serum TxB2 and arachidonic acid-induced TxB2 production was found (r?=?0.76619). 相似文献
6.
Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly 下载免费PDF全文
7.
8.
9.
10.